Why Promising Drugs Struggle After FDA Approval: Understanding the Barriers to Market Success
For most drug developers, FDA approval feels like the finish line. Then launch day arrives and the real test begins.FDA approval confirms that a drug has met the applicable regulatory requirements for ...
Clinical Differentiation Is No Longer Enough: How “Access Differentiation” Is Becoming the Real Moat
A therapy can post best-in-class trial data and still stall at launch. Not because the science was wrong, but because nobody could tell a payer what happens after the trial ends, when the drug meets r ...